[HTML][HTML] Development of novel galactosylated PLGA nanoparticles for hepatocyte targeting using molecular modelling

CD Raposo, R Costa, KT Petrova, C Brito, MT Scotti… - Polymers, 2020 - mdpi.com
Doxorubicin-loaded PLGA nanoparticles conjugated with a new galactose-based ligand for
the specific recognition by human hepatoma cellular carcinoma cells (Hep G2) were …

[PDF][PDF] Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling

CD Raposo, R Costa, KT Petrova, C Brito, MT Scotti… - novaresearch.unl.pt
Doxorubicin-loaded PLGA nanoparticles conjugated with a new galactose-based ligand for
the specific recognition by human hepatoma cellular carcinoma cells (Hep G2) were …

[HTML][HTML] Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling

CD Raposo, R Costa, KT Petrova, C Brito, MT Scotti… - Polymers, 2020 - ncbi.nlm.nih.gov
Doxorubicin-loaded PLGA nanoparticles conjugated with a new galactose-based ligand for
the specific recognition by human hepatoma cellular carcinoma cells (Hep G2) were …

[PDF][PDF] Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling

CD Raposo, R Costa, KT Petrova, C Brito, MT Scotti… - run.unl.pt
Doxorubicin-loaded PLGA nanoparticles conjugated with a new galactose-based ligand for
the specific recognition by human hepatoma cellular carcinoma cells (Hep G2) were …

[PDF][PDF] Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling

CD Raposo, R Costa, KT Petrova, C Brito, MT Scotti… - research.unl.pt
Doxorubicin-loaded PLGA nanoparticles conjugated with a new galactose-based ligand for
the specific recognition by human hepatoma cellular carcinoma cells (Hep G2) were …

Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling.

CD Raposo, R Costa, KT Petrova, C Brito, MT Scotti… - Polymers, 2020 - europepmc.org
Doxorubicin-loaded PLGA nanoparticles conjugated with a new galactose-based ligand for
the specific recognition by human hepatoma cellular carcinoma cells (Hep G2) were …

Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling

CD Raposo, R Costa, KT Petrova, C Brito… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Doxorubicin-loaded PLGA nanoparticles conjugated with a new galactose-based ligand for
the specific recognition by human hepatoma cellular carcinoma cells (Hep G2) were …

Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling.

CD Raposo, R Costa, KT Petrova, C Brito… - Polymers …, 2020 - search.ebscohost.com
Doxorubicin-loaded PLGA nanoparticles conjugated with a new galactose-based ligand for
the specific recognition by human hepatoma cellular carcinoma cells (Hep G2) were …

Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling

CD Raposo, R Costa, KT Petrova, C Brito, MT Scotti… - …, 2020 - search.proquest.com
Doxorubicin-loaded PLGA nanoparticles conjugated with a new galactose-based ligand for
the specific recognition by human hepatoma cellular carcinoma cells (Hep G2) were …

[PDF][PDF] Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling

CD Raposo, R Costa, KT Petrova, C Brito, MT Scotti… - research.unl.pt
Doxorubicin-loaded PLGA nanoparticles conjugated with a new galactose-based ligand for
the specific recognition by human hepatoma cellular carcinoma cells (Hep G2) were …